News | Radiation Oncology | November 23, 2015

Texas Center for Proton Therapy Now Treating Patients

Collaboration between physicians network and health care system offers cancer patients in the Dallas-Fort Worth metropolitan area access to IBA proton therapy 

Texas Center for Proton Therapy Now Treating Patients

IBA (Ion Beam Applications S.A.) announced that the newly opened Texas Center for Proton Therapy is now treating cancer patients, using image-guided Pencil Beam Scanning (PBS).

The 63,000-square-foot facility features a three-room Proteus PLUS proton therapy system consisting of one fixed-beam treatment room and two 360° isocentric gantry treatment rooms. Special care has been taken to incorporate an environmental-friendly design, construction, operation and maintenance of the facility, making Texas Center for Proton Therapy the first stand-alone LEED-Certified proton therapy center in the U.S.

PBS availability in all three rooms makes Texas Center for Proton Therapy the largest pencil beam proton center in the state. This highly-precise delivery modality allows for Intensity Modulated Proton Therapy (IMPT) and is furthermore supported by an on-board Cone Beam CT (CBCT) offering 3-D volumetric imaging. The configuration also includes some of the most advanced PET/CT and 3-Tesla MRI scanning and imaging technology available, as well as on-site lab services. A skilled staff, combining more than 70 years of proton experience, ensures optimal clinical use of this advanced technology.

The first gantry room is installed, and is equipped with a universal nozzle, allowing PBS, as well as Double Scattering (DS) treatment modes. The rigging was done on July 1st, 2014, the first patients being treated only 16 months later, three months in advance of the initial schedule. Treatment in the second gantry is anticipated in the 1st quarter of 2016.

Andrew K. Lee, M.D., M.P.H., medical director at Texas Center for Proton Therapy, commented: “The benefits of proton therapy for cancer treatment include the ability to treat cancer with utmost precision, minimizing damage to healthy tissue and enhancing quality of life for patients during and after treatment. New technologies from IBA allow us to better leverage this beneficial treatment, and a fully equipped center like this is an important boost to cancer treatment in Texas.”

Gary Barlow, director at Texas Center for Proton Therapy, commented: “Lacking any local access to proton therapy, residents of Dallas-Fort Worth previously had no choice but to travel if they wanted to benefit from this radiation treatment modality. We are thrilled to see our efforts fulfilled and patients benefitting from this advanced technology. We are looking forward to gradually building up our activities toward our full capacity to treat more than 100 patients a day.”

Olivier Legrain, IBA’s CEO, said: “It is our mission to make proton therapy accessible to every patient who can benefit from it. It is very satisfying to know that 6.5 million people will no longer need to travel long distances at great expense if they are in need of proton therapy treatment. IBA is proud to be a partner in bringing this advantageous treatment modality within their vicinity. Every new center treating patients is another battle won in the worldwide fight against cancer.”

Beth Klein, president of IBA Proton Therapy North America, adds: “IBA is proud to play a role in providing our state of the art technology to the physicians of Texas Center for Proton Therapy. We expect to see more collaborative partnerships in the future that provide the highest quality proton therapy treatment at a cost that ultimately may prove to be lower than conventional radiation therapy treatment for some cancers.”

For more information: www.TexasCenterforProtonTherapy.com

Related Content

Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
A model of the new, compact, single-room Varian ProBeam 360 system. The system is an example of the trend in proton therapy toward single-room, smaller systems and away from multi-room treatment centers. #ASTRO18 #ASTRO2018

A model of the new, compact, single-room Varian ProBeam 360 system. The system is an example of the trend in proton therapy toward single-room, smaller systems and away from multi-room treatment centers.

Feature | Proton Therapy | November 01, 2018 | Dave Fornell, Editor
A few of the big takeaways from the American Societ...
Victoria Advisory Committee for Proton Therapy Launched at ASTRO 2018
News | Proton Therapy | October 29, 2018
At the 2018 American Society for Radiation Oncology (ASTRO) annual meeting, IBA announced the launch of the Victoria...
Beaumont Hospital Cancer Institute Performs First Irradiation of Spot Scanning Proton Arc Therapy Plan
News | Proton Therapy | October 25, 2018
IBA announced the first irradiation of a Spot Scanning Proton Arc (SPArc) plan at the Beaumont Health Proton Therapy...
Varian Introduces New ProBeam 360° Proton Therapy System
News | Proton Therapy | October 23, 2018
Varian announced its new single-room proton therapy system, ProBeam 360°, at the 2018 American Society of Radiation...
Amar U. Kishan, M.D., presents data about stereotactic body radiation therapy at ASTRO 2018. #ASTRO #ASTRO18 #ASTRO2018

Amar U. Kishan, M.D., presents data about stereotactic body radiation therapy at ASTRO 2018.

Feature | Stereotactic Body Radiation Therapy (SBRT) | October 23, 2018 | By Greg Freiherr
With its shorter course of treatment,...
IBA's Proteus system and proton therapy solutions will be discussed at ASTRO 2018. #ASTRO18 #ASTRO #ASTRO2018
News | Proton Therapy | October 19, 2018
October 19, 2018 – IBA (Ion Beam Applications S.A.) is sharing how hospitals can secure performance, investment and t